Cargando…

Cell-Free Circulating (Tumor) DNA before Surgery as a Prognostic Factor in Non-Metastatic Colorectal Cancer: A Systematic Review

SIMPLE SUMMARY: Patients with colorectal cancer without distant metastases are often cured by surgical tumor resection. Follow-up is needed because of the risk of disease recurrence. Patients at risk of disease recurrence may benefit from additional chemotherapy. Detection of cell-free circulating t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schraa, Suzanna J., van Rooijen, Karlijn L., Koopman, Miriam, Vink, Geraldine R., Fijneman, Remond J. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101623/ https://www.ncbi.nlm.nih.gov/pubmed/35565347 http://dx.doi.org/10.3390/cancers14092218

Ejemplares similares

Comparison of NTRK fusion detection methods in microsatellite-instability-high metastatic colorectal cancer
por: Schraa, Suzanna J., et al.
Publicado: (2023)

Translation of IDEA trial results into clinical practice: Analysis of the implementation of a new guideline for colon cancer
por: van Rooijen, Karlijn L., et al.
Publicado: (2022)

Predicting early extrahepatic recurrence after local treatment of colorectal liver metastases
por: Wensink, G E, et al.
Publicado: (2023)

Time‐varying prognostic value of primary tumor sidedness in metastatic colorectal cancer: A population‐based study and meta‐analysis
por: van der Kruijssen, Dave E. W., et al.
Publicado: (2022)

Postoperative circulating tumour DNA is associated with pathologic response and recurrence-free survival after resection of colorectal cancer liver metastases
por: Bolhuis, Karen, et al.
Publicado: (2021)

A Systematic Review of the Use of Circulating Cell-Free DNA Dynamics to Monitor Response to Treatment in Metastatic Breast Cancer Patients
por: Jongbloed, Elisabeth M., et al.
Publicado: (2021)

Informing metastatic colorectal cancer patients by quantifying multiple scenarios for survival time based on real‐life data
por: Hamers, Patricia A. H., et al.
Publicado: (2020)

Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study
por: Schraa, S. J., et al.
Publicado: (2020)

Paving the Road Towards Non-Invasive Molecular Imaging
por: Fijneman, Remond J.A.
Publicado: (2006)

Genetic Predisposition to Sporadic Cancer: How to Handle Major Effects of Minor Genes?
por: Fijneman, Remond J. A.
Publicado: (2005)

Genome-wide cell-free DNA fragmentation in patients with cancer
por: Cristiano, Stephen, et al.
Publicado: (2019)

Metastatic Colorectal Cancer Treatment Response Evaluation by Ultra-Deep Sequencing of Cell-Free DNA and Matched White Blood Cells
por: van 't Erve, Iris, et al.
Publicado: (2023)

Performance of four platforms for KRAS mutation detection in plasma cell-free DNA: ddPCR, Idylla, COBAS z480 and BEAMing
por: Vessies, D. C. L., et al.
Publicado: (2020)

Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study
por: Salvianti, Francesca, et al.
Publicado: (2021)

Meta-Analysis of Circulating Cell-Free DNA’s Role in the Prognosis of Pancreatic Cancer
por: Milin-Lazovic, Jelena, et al.
Publicado: (2021)

Circulating Free DNA as Biomarker and Source for Mutation Detection in Metastatic Colorectal Cancer
por: Spindler, Karen Lise Garm, et al.
Publicado: (2015)

External Validation of Two Established Clinical Risk Scores Predicting Outcome after Local Treatment of Colorectal Liver Metastases in a Nationwide Cohort
por: Bolhuis, Karen, et al.
Publicado: (2022)

Circulating Tumour DNA as Biomarker for Colorectal Liver Metastases: A Systematic Review and Meta-Analysis
por: Wullaert, Lissa, et al.
Publicado: (2023)

Circulating Tumor DNA Analysis: Clinical Implications for Colorectal Cancer Patients. A Systematic Review
por: Bach, Sander, et al.
Publicado: (2019)

Prognostic value of circulating endothelial cells in metastatic colorectal cancer
por: Rahbari, Nuh N, et al.
Publicado: (2017)

Colorectal Cancer Care and Patients’ Perceptions Before and During COVID-19: Implications for Subsequent SARS-CoV-2 Infection Waves
por: Derksen, Jeroen W G, et al.
Publicado: (2021)

Circulating Cell-Free DNA in Liquid Biopsies as Potential Biomarker for Bladder Cancer: A Systematic Review
por: Herranz, Raquel, et al.
Publicado: (2021)

Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer
por: Hao, T B, et al.
Publicado: (2014)

Treatment monitoring in metastatic colorectal cancer patients by quantification and KRAS genotyping of circulating cell-free DNA
por: Berger, Andreas W., et al.
Publicado: (2017)

A systematic review of treatment guidelines for metastatic colorectal cancer
por: Edwards, M S, et al.
Publicado: (2012)

Prognostic Role of Circulating Tumor Cell Trajectories in Metastatic Colorectal Cancer
por: Magri, Valentina, et al.
Publicado: (2023)

Circulating Cell-Free DNA Methylation Profiles in the Early Detection of Ovarian Cancer: A Scoping Review of the Literature
por: Guo, Xiaoyue M., et al.
Publicado: (2021)

The Prognostic Value of Circulating Cell-Free DNA in Colorectal Cancer: A Meta-Analysis
por: Basnet, Shiva, et al.
Publicado: (2016)

Prognostic value of Lynch syndrome, BRAF(V600E) , and RAS mutational status in dMMR/MSI‐H metastatic colorectal cancer in a pooled analysis of Dutch and French cohorts
por: Zwart, Koen, et al.
Publicado: (2023)

Gene Mutations in Circulating Tumour DNA as a Diagnostic and Prognostic Marker in Head and Neck Cancer—A Systematic Review
por: Hudečková, Markéta, et al.
Publicado: (2021)

Role of circulating free DNA in colorectal cancer
por: Matikas, Alexios, et al.
Publicado: (2016)

Clinical Characteristics of Metastatic Colorectal Cancer Combined with Gastrointestinal Perforation and Prognostic Value of Circulating Tumor DNA
por: Yang, Hong, et al.
Publicado: (2022)

Investigating the Role of Circulating miRNAs as Biomarkers in Colorectal Cancer: An Epidemiological Systematic Review
por: Dansero, Lucia, et al.
Publicado: (2022)

Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN)
por: Jongeneel, Gabrielle, et al.
Publicado: (2020)

External Validation of the Colon Life Nomogram for Predicting 12-Week Mortality in Dutch Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil in Daily Practice
por: Hamers, Patricia A. H., et al.
Publicado: (2022)

Immune-Checkpoint Inhibitors for Metastatic Colorectal Cancer: A Systematic Review of Clinical Outcomes
por: Shek, Dmitrii, et al.
Publicado: (2021)

The Role of Circulating Tumor Cells in the Prognosis of Metastatic Triple-Negative Breast Cancers: A Systematic Review of the Literature
por: Lisencu, Lorena Alexandra, et al.
Publicado: (2022)

MicroRNA-143 is a putative predictive factor for the response to fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer
por: Simmer, Femke, et al.
Publicado: (2015)

Circulating Cell Free DNA Integrity Index as a Biomarker for Response to Chemotherapy in Patients with Metastatic Colorectal Carcinoma
por: Eskander, Nancy Samir, et al.
Publicado: (2022)

Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands
por: Kwakman, Johannes J. M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gjh4a0qtlid5to209mlod7n9cs